Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Aeffner F, Wilson K, Martin NT, Black JC, Hendriks CLL, Bolon B, Young GD. The gold standard paradox in digital image analysis: manual versus automated scoring as ground truth. Arch Pathol Lab Med. 2017;141(9):1267–75. https://doi.org/10.5858/arpa.2016-0386-RA.
2. Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Wolff AC. Estrogen and progesterone receptor testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists guideline update. Arch Pathol Lab Med. 2020;144(5):545–63. https://doi.org/10.5858/arpa.2019-0904-SA.
3. Akbar S, Jordan LB, Purdie CA, Thompson AM, McKenna SJ. Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays. Br J Cancer. 2015;113(7):1075–80. https://doi.org/10.1038/bjc.2015.309.
4. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11(2):155–68.
5. Aperio Technologies Inc. 510(k) Summary of Substantial Equivalence Aperio Technologies, Inc. (ScanScope® XT System). Aperio Technologies Inc., California, United States; 2007 [cited 2020 Jun 18]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf7/K071128.pdf. Accessed 10 Jun 2019.